INTRODUCTION
============

Aggregation of FcɛRI results in the phosphorylation of two tyrosine residues within its immunoreceptor tyrosine-based activation motif (ITAM) by Lyn, or by another member of the Src family of tyrosine kinases that associates with the receptor. Phosphorylated ITAM then serves as a docking site for Syk, and this interaction leads to the downstream propagation of signals. Syk phosphorylates adapter proteins, such as, linker for the activation of T cells (LAT), and these phosphorylations result in the formation of a macromolecular signaling complex that allows the diversification of downstream signals required for the release of various pro-inflammatory mediators ([@b26-bt-22-3-193]). These signaling pathways include phospholipase Cγ (PLCγ)-mediated Ca^2+^ mobilization, which is a prerequisite for mast cell degranulation and subsequent arachidonic acid (AA) release from membranes by cytosolic phospholipase A~2~ (cPLA~2~), which is activated by an increase in Ca^2+^ influx and phosphorylation by MAPKs ([@b3-bt-22-3-193]; [@b5-bt-22-3-193]). Therefore, blockade of Syk kinase could inhibit the allergen-induced releases of multiple granule-stored and newly synthesized mediators ([@b19-bt-22-3-193]). FcɛRI crosslinking also induces the activations of the mitogen-activated protein kinase (MAPK), phosphatidylinositol-3-kinase (PI3K)/Akt, and NF-κB signaling pathways, which ultimately contribute to the inducible expressions of multiple pro-inflammatory genes, such as, cytokines and cyclooxygenase (COX)-2.

The flowers of *Inular japonica* (*I. japonica*, Inulae Flos) have long been used in traditional Chinese medicine for the treatment of digestive disorders, bronchitis, and inflammation ([@b13-bt-22-3-193]). Modern pharmacological studies have also described its diverse effects in the contexts of anti-diabetes, hypolipidemia, and hepatoprotection ([@b27-bt-22-3-193]; [@b11-bt-22-3-193]; [@b25-bt-22-3-193]). Our group previously reported that the ethanol extract of *I. japonica* exhibited anti-asthmatic ([@b22-bt-22-3-193]) and anti-allergic activities ([@b15-bt-22-3-193]) in an *in vivo* animal model. Previously, we reported that the ethanol extract of *I. japonica* inhibited degranulation, eicosanoid generation, and *in vivo* antiallergic activity. In this previous report, we isolated three major sesquiterpenes by HPLC, and described the inhibitions of degranulation and eicosanoid generation by britanin and tomentosin in SCF-induced BMMCs ([@b15-bt-22-3-193]). In addition, we previously also found that the ethanol extract of *I. japonica* suppressed macrophages activation by LPS and that britanin suppressed the productions of nitric oxide, PGE~2~ and proinflammatory cytokines in LPS-stimulated RAW264.7 cells ([@b2-bt-22-3-193]; [@b21-bt-22-3-193]). However, the mechanisms underlying the inhibitions of degranulation and eicosanoid generation by britanin have not been well established. Accordingly, we sought to determine whether britanin modulates the generation of allergic inflammatory mediators in activated mast cells. In the present study, we demonstrated that britanin inhibits degranulation, PGD~2~ and LTC~4~ generation in IgE/Ag-induced BMMCs by suppression of the Syk pathway.

MATERIALS AND METHODS
=====================

Plant material
--------------

Britanin was isolated from *Inulae Flos* by methanol extraction as described previously ([@b21-bt-22-3-193]). Britanin was dissolved in 0.1% (v/v) dimethyl sulfoxide (DMSO), which did not affect BMMCs viability or activation. Therefore, a control consisting of DMSO alone was also run in all cases.

Chemicals and reagents
----------------------

Mouse anti-dinitrophenyl (DNP) IgE and DNP-human serum albumin (HSA) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Primary antibodies used were used: rabbit polyclonal antibodies specific for phospho-IκB, IKKα/β, ERK1/2, JNK, PLCγ1, p38, β-actin, and total form for IκB, ERK1/2, JNK, p38, and 5-LO were purchased from Cell Signaling Technology, Inc. (Danvers, MA, USA). Rabbit polyclonal antibodies against NF-κB p65, Syk, LAT, PLCγ1, phospho-cPLA~2~ (Ser505), IKKα/β and lamin B as well as secondary goat anti-rabbit IgG-HRP and rabbit anti-goat IgG-HRP antibodies, total Syk, total LAT, and Bay 61-3606 were purchased from Santa Cruz Biotechnology (Dallas, TX, USA) and antibodies for phosphotyrosine was purchased from Millipore (Millipore, Billerica, MA, USA). The enzyme immnoassay (EIA) kits for PGD~2~ and LTC~4~ were purchased from Cayman Chemicals (Ann Arbor, MI, USA).

Mouse bone marrow-derived mast cells (BMMCs) culture and activation
-------------------------------------------------------------------

BMMCs were isolated from male Balb/cJ mice (Sam Taco, INC, Seoul, Korea) and were cultured at 37°C in RPMI 1640 media (Thermo Scientific, UT, USA) containing 10% fetal bovine serum (FBS), 100 U/ml of penicillin (Thermo Scientific, Utah, USA), 10 mM HEPES buffer (Sigma-Aldrich, St. Louis, MO, USA), 100 μM MEM non-essential amino acid solution (Invitrogen, Carlsbad, CA, USA) and 20% PWM-SCM (poke-weed mitogen-spleen cell conditioned medium) as a source of IL-3. After 6 weeks, \>98% of the cells was found to be BMMCs as determined by a previously described procedure, as described previously ([@b17-bt-22-3-193]). For BMMCs stimulation, 10^6^ cells/ml were sensitized overnight with 500 ng/ml of anti-DNP IgE, 1 h pretreated with indicated concentration of britanin or Bay 61-3606, and then stimulated for 15 min with 100 ng/ml of DNP-HSA.

Degranulation assays
--------------------

After stimulating with DNP-HSA for 15 min with or without pretreatment with britanin or Bay 61-3606 for 1 h, degranulation was determined by measuring the release of β-hexosaminidase (β-Hex), a marker of mast cell degranulation, by a spectrophotometric method, as described previously ([@b15-bt-22-3-193]).

MTT assay for cell viability
----------------------------

Cell viability was assessed by MTT (Sigma) assay. Briefly, BMMCs were seeded onto 96 well culture plates at 2×10^4^ cells/200 ml/well. After incubation with various concentrations of britanin for 8 h, 20 μl of MTT (5 mg/ml) was added to each well. After 4 h incubation, 150 μl of culture medium was removed, and cells were dissolved in 0.4 N HCl/isopropyl alcohol. The optical densities (OD) at 570 nm and 630 nm were measured using a microplate reader (Sunrise, Tecan, Switzerland).

Measurement of LTC~4~ and PGD~2~ amounts
----------------------------------------

IgE sensitized BMMCs were pretreated with britanin or Bay 61-3606 for 1 h and stimulated with DNP-HSA (100 ng/ml). After 15 min of stimulation, the supernatants were isolated for further analysis by EIA. LTC~4~ was determined using an enzyme immunoassay kit. To assess COX-2-dependent PGD~2~ synthesis, BMMCs were preincubated with 1 μg/ml of aspirin for 2 h to irreversibly inactivate preexisting COX-1. After washing, BMMCs were activated with DNP-HSA (100 ng/ml) at 37°C for 7 h with britanin or Bay 61-3606. PGD~2~ in the supernatants were quantified using PGD~2~ EIA kit and cells were used for immunoblots analysis.

Measurement of intracellular Ca^2+^ level
-----------------------------------------

Intracellular Ca^2+^ level was determined with FluoForte^TM^ Calcium Assay Kit (Enzo Life Sciences, Ann Arbor, MI, USA), as described previously ([@b9-bt-22-3-193]). Briefly, BMMCs were preincubated with FluoForte^TM^ Dye-Loading Solution for 1 h at room temperature. After washing the dye from cell surface with PBS, the cells (5×10^4^) were seeded into 96-well microplates. Then the cells were pretreated with britanin or Bay 61-3606 for 1 h before adding DNP-HSA. The fluorescence was measured using a flurometric imaging plated reader at an excitation of 485 nm and an emission of 520 nm (BMG Labtechnologies FLUOStar OPITIMA platereader, Offenburg, Germany). All the assay experiments were independently repeated at least three times.

Preparation of nuclear and cytoplasmic extracts
-----------------------------------------------

The nuclear and cytoplasmic extracts were prepared as described previously ([@b17-bt-22-3-193]). BMMCs were sensitized to DNP-specific IgE (500 ng/ml, overnight) and pretreated with britanin or Bay 61-3606 for 1 h, and then stimulated with DNPHSA (100 ng/ml) for 30 min. Cultured BMMCs were collected by centrifugation, washed with PBS and lysed in a buffer containing 10 mM HEPES (pH 7.9), 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 1 mM phenylmethanesulfonylfluo-ride (PMSF) and 0.1% NP40 by incubation on ice for 10 min. After centrifugation at 1,000 *g* for 4 min, supernatants were used as a cytosolic fraction. Nuclear pellets were washed and lysed in a buffer containing 20 mM HEPES (pH 7.9), 25% (v/v) glycerol, 420 mM NaCl, 1.5 mM MgCl~2~, 0.2 mM EDTA, and the protease inhibitor cocktail. This suspension was incubated for 30 min at 4°C followed by centrifugation at 10,000 *g*, and the resultant supernatants were used as a nuclear fraction.

Immunoprecipitation (IP)
------------------------

Immunoblotting was performed as described previously ([@b17-bt-22-3-193]). Cell lysates were obtained using modified lysis buffer \[0.1% Nonidet P-40, 50 mM HEPES (pH 7.0), 250 mM NaCl, 5 mM EDTA, 1 mM PMSF, and 0.5 mM dithiothreitol\]. Total cell lysates (1 mg protein equivalent) were incubated with anti-Syk or anti-LAT antibodies for 2 h at 4°C and immunocomplexes were precipitated with 20 μl of protein A-Sepharose. Immunocomplex precipitates were then extensively washed (3 times) with ice-cold lysis buffer. These precipitates or total cell lysates were subjected to SDS-PAGE and immunoblotted with corresponding antibodies.

Western blotting
----------------

Western blotting was performed as described previously ([@b17-bt-22-3-193]). BMMCs were lysed in RIPA lysis buffer (50 mM Tris-HCl \[pH 8.0\], 150 mM NaCl, 5 mM EDTA, 1% Nonidet P-40, 1mM phenylmethanesulfonylfluoride (PMSF), 1M dithiothreitol (DTT), 200 mM NaF, 200 mM Na~3~VO~4~, and a protease inhibitor cocktail). Cell debris was removed by centrifugation at 14,000×*g* for 15 min at 4°C and resulting supernatant were used for western blotting. Protein concentration was measured using the Qubit Fluorometer machine (Invitrogen, USA). Samples were separated by 8% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred to nitro-cellulose transfer membrane (Millipore, Billerica, MA, USA). The membranes were then blocked with 5% nonfat dry milk in Tris-buffered saline containing 0.1% Tween 20 and incubated with individual antibodies; primary antibodies were diluted at 1:1000 (unless otherwise stated) and incubated at 4°C overnight. Membranes were then washed three times for 10 min each with TBS-T buffer, and immunoreactive proteins were incubated with HRP-coupled secondary antibodies diluted at 1:3000 for 1 h at room temperature, washed three times for 10 min with TBS-T buffer, and developed using enhanced chemiluminescence (ECL) detection kits (Pierce Biotechnology, Rockford, IL, USA).

Statistic Analysis
------------------

All experiments were performed three or more times. Average values are expressed as means ± S.D. Statistical analyses were performed using SPSS 19.0 (SPSS, Chicago, IL, USA). The Student's *t*-test was used to compare pairs of independent groups. Statistical significance was accepted for *p* values \<0.05.

RESULTS
=======

Effects of britanin on degranulation, eicosanoid generation, and intracellular calcium influx in IgE/Ag-induced BMMCs
---------------------------------------------------------------------------------------------------------------------

Initially, the cytotoxicity of britanin on BMMCs was examined using the MTT assay. However, britanin did not affect cell viability up to a concentration of 20 μM ([Fig. 1A](#f1-bt-22-3-193){ref-type="fig"}). Therefore, britanin levels from 1 to 10 μM were used in subsequent experiments. Previously, we reported that PGD~2~ generation by BMMCs is biphasic. More specifically, after IgE/Ag stimulation, immediate (occurring within 2 h) PGD~2~ generation, which is regulated by constitutive COX-1, is followed by delayed (2--10 h) PGD~2~ generation, which is regulated by inducible COX-2 ([@b20-bt-22-3-193]; [@b17-bt-22-3-193]; [@b9-bt-22-3-193]). As shown in [Fig. 1B](#f1-bt-22-3-193){ref-type="fig"}, IgE/Ag-induced BMMCs showed significant augmentation of the delayed phase of PGD~2~ generation and amplification of COX-2 induction. In order to evaluate delayed COX-2-dependent PGD~2~ generation, BMMCs were pre-treated with aspirin to abolish preexisting COX-1 activity, briefly washed, and then stimulated with DNP-HSA in the presence or absence of britanin or Bay 61-3606 (a Syk inhibitor) for 7 h. The generation of PGD~2~ was found to be dose-dependently suppressed by britanin and COX-2 expression was concomitantly reduced. Next, we examined the effect of britanin on 5-lipoxygenase (5-LO) dependent LTC~4~ generation, and we found that LTC~4~ generation was also inhibited by britanin and by Bay 61-3606 ([Fig. 1C](#f1-bt-22-3-193){ref-type="fig"}). We also examined the effect of britanin on the exocytotic secretion of β-Hex, a degranulation marker enzyme in BMMC, and found β-Hex release was markedly inhibited by britanin and by Bay 61-3606 ([Fig. 1D](#f1-bt-22-3-193){ref-type="fig"}). Intracellular Ca^2+^ elevation is one of the earliest events and is essential for mast cell degranulation and AA release from phospholipid and for the metabolism of phospholipid ([@b3-bt-22-3-193]; [@b6-bt-22-3-193]; [@b7-bt-22-3-193]). Therefore, we examined whether britanin affects Ca^2+^ signals in IgE/Ag-induced BMMCs. As shown in [Fig. 1E](#f1-bt-22-3-193){ref-type="fig"}, pretreatment of BMMCs with britanin or Bay 3606 significantly decreased intracellular Ca^2+^ levels.

Effect of britanin on cPLA~2~α- and 5-LO-dependent LTC~4~ generation
--------------------------------------------------------------------

The generation of LTC~4~ is regulated by two steps, namely, the liberation of AA from membrane phospholipids by cPLA~2~ and the oxygenation of free AA by 5-LO. Both 5-LO and cPLA~2~α translocate from the cytosol to the nuclear membrane in response to an increase in intracellular Ca^2+^ level ([@b6-bt-22-3-193]; [@b7-bt-22-3-193]), and cPLA~2~α is phosphorylated by MAPKs (a process necessary for the maximal release of AA) ([@b12-bt-22-3-193]; [@b17-bt-22-3-193]). We first examined the effect of britanin on the phosphorylations and nuclear translocations of cPLA~2~ and 5-LO. As was observed in our previous study ([@b17-bt-22-3-193]; [@b16-bt-22-3-193]), DNP-HSA stimulation caused the translocation of some cytosolic phosphorylated cPLA~2~α to nuclear fractions ([Fig. 2](#f2-bt-22-3-193){ref-type="fig"}). 5-LO was localized mainly in cytosol in unstimulated BMMCs ([Fig. 2A](#f2-bt-22-3-193){ref-type="fig"}), but DNP-HSA stimulation caused the translocation of most 5-LO to the nuclear fraction ([Fig. 2B](#f2-bt-22-3-193){ref-type="fig"}). Furthermore, the appearance of both cytosolic and nuclear phospho-cPLA~2~α and the translocation of 5-LO were inhibited by britanin and by Bay 61-3606. These results suggest that britanin and Bay 61-3606 inhibited LTC~4~ generation by inhibiting cPLA~2~α translocation, which suggests that the Syk pathway is required for LTC~4~ generation, as has been described previously ([@b17-bt-22-3-193]; [@b16-bt-22-3-193]).

Effect of britanin on the IKK-IκBα-NF-κB pathway
------------------------------------------------

Since NF-κB is an essential transcription factor for several inflammatory genes, such as, COX-2, iNOS, and tumor necrosis factor-α (TNF-α) ([@b23-bt-22-3-193]; [@b28-bt-22-3-193]), we examined whether the inhibition of COX-2 by britanin suppresses NF-κB activation pathways. We and others have previously reported that the phosphorylation and subsequent degradation of IκB by IKK leads to the nuclear translocation of NF-κB p65 ([@b23-bt-22-3-193]; [@b28-bt-22-3-193]; [@b16-bt-22-3-193]). To investigate the IgE/Ag-mediated activation of the IKK-IκBα-NF-κB pathway, BMMCs were simulated with DNP-HSA for 15 or 30 min, cytoplasmic or nuclear proteins were then examined for the phosphorylations of IKKα/β and IκBα and total protein levels. Pretreatment of BMMCs with britanin decreased the phosphorylation of IKKα/β and IκBα the degradation of IκBα ([Fig. 3A](#f3-bt-22-3-193){ref-type="fig"}), and the nuclear translocation of NF-κB p65 subunit ([Fig. 3B](#f3-bt-22-3-193){ref-type="fig"}). Bay 61-3606 also inhibited these signal events, indicating that the IKK-IκBα-NF-κB pathway was under the control of Syk.

Effects of britanin on MAPKs activation in IgE-sensitized BMMCs
---------------------------------------------------------------

Previously, we reported that the inhibition of COX-2 expression and of attendant PGD~2~ generation occurred after NF-κB inactivation and/or treating cells with either of three MAPKs inhibitors, that is, U0126 for extracellular regulated kinase1/2 (ERK1/2), SP600125 for c-jun N-terminal kinase (JNK), or SB03580 for p38 MAP kinase ([@b17-bt-22-3-193]). As shown in [Fig. 4](#f4-bt-22-3-193){ref-type="fig"}, when BMMCs were pretreated with britanin or Bay 61-3606 for 1 h, both compounds clearly and dose-dependently inhibited the IgE/Ag-induced phosphorylation of ERK1/2, JNK, and p38 MAP kinase. This result suggests that the inhibition of Syk by britanin may suppress MAPK activation.

Britanin inhibited Syk activation
---------------------------------

The tyrosine kinase Syk plays an essential role in the initiation of the FcɛRI-dependent signaling pathway, and thus, we examined whether britanin affects the phosphorylation of Syk, and the phosphorylations of LAT and PLCγ1, which lie immediately downstream of Syk ([@b17-bt-22-3-193]; [@b16-bt-22-3-193]). As shown in [Fig. 5](#f5-bt-22-3-193){ref-type="fig"}, the tyrosine phosphorylation of Syk, LAT, and PLCγ1 were observed in IgE/Ag-induced BMMCs, and these phosphorylation were significantly and dose-dependently inhibited by britanin. Under the same conditions, the Syk inhibitor Bay 61-3606 (positive control) potently inhibited the phosphorylation of Syk, PLCγ1, and LAT.

DISCUSSION
==========

To explore the biological activity of britanin, we investigated its effects on the generation of PGD~2~, LTC~4~, and degranulation in IgE/Ag-induced BMMCs. This study shows that britanin inhibits degranulation, PGD~2~ and LTC~4~ generation in IgE/Ag-induced BMMCs by suppressing the Syk pathway. Several sesquiterpenes, namely, britanin, tomentosin ([@b15-bt-22-3-193]), ergolide, acetylbritannilactone ([@b8-bt-22-3-193]; [@b10-bt-22-3-193]; [@b14-bt-22-3-193]) and sesquiterpenes dimer inulanolides ([@b10-bt-22-3-193]) have been isolated from *I. japonica* and evaluated for their biological activities. Ergolide, inulanolide, and britanin have been reported to inhibit the expressions of iNOS, COX-2, or TNF-α in LPS-stimulated RAW264.7 cells, whereas inulanolides inhibited LPS-induced inflammatory response in vascular smooth muscle cell ([@b8-bt-22-3-193]; [@b13-bt-22-3-193]; [@b10-bt-22-3-193]; [@b14-bt-22-3-193]; [@b21-bt-22-3-193]). Previously, we reported that *I. japonica* suppresses ovalbumin-induced airway inflammation and IgE/Ag-stimulated passive cutaneous anaphylaxis in a mouse model ([@b22-bt-22-3-193]; [@b15-bt-22-3-193]). However, we only described the effects of britanin on SCF-induced mast cell activation ([@b15-bt-22-3-193]), and thus, the mechanism responsible for the inhibitory effect of britanin on IgE/Ag-induced mast cell activation has not been reported.

When mast cells are activated by the cross-linking of IgE/Ag on their membranes, the Lyn/Syk/LAT axis phosphorylates PLCγ1 causing Ca^2+^ influx, which triggers degranulation and activates AA metabolizing enzymes ([@b4-bt-22-3-193]). The present study shows that britanin markedly inhibits the phosphorylations of Syk, LAT, and PLCγ1 ([Fig. 5](#f5-bt-22-3-193){ref-type="fig"}) and intracellular Ca^2+^ influx ([Fig. 1E](#f1-bt-22-3-193){ref-type="fig"}), and results in the inhibition of degranulation in IgE/Ag-induced BMMCs. Furthermore, britanin was found to dose-dependently inhibit the 5-LO dependent LTC~4~ generation that occurs within 15 min of treatment when IgE binds to FcɛRI on the membranes of BMMCs ([Fig. 1C](#f1-bt-22-3-193){ref-type="fig"}). Other groups have reported that the synthesis of LTC~4~ in mast cells is regulated by two steps, that is, by the activation of cPLA~2~α by MAPKs to facilitate the release of AA from membrane phospholipid, and by the conversion of free AA to LTC~4~ by 5-LO and nuclear transmembrane protein 5-LO-activating protein (FLAP), the latter of which may serve as an AA binding protein on the outer nuclear membrane ([@b18-bt-22-3-193]). The results of the present study demonstrate that the inhibition of 5-LO dependent LTC~4~ generation by britanin is due to the inhibition of cPLA~2~α phosphorylation by MAPKs and to the inhibition of the translocations of phospho-cPLA~2~α and 5-LO to the nuclear membrane ([Fig. 2](#f2-bt-22-3-193){ref-type="fig"}).

The other AA metabolite PGD~2~ (the major prostaglandin) is produced by the COX pathway in mast cells ([@b6-bt-22-3-193]). In the present study, after inactivating preexisting COX-1 activity using aspirin, BMMCs cells were stimulated with DNP-HSA for 7 h with or without britanin. As shown in [Fig. 1B](#f1-bt-22-3-193){ref-type="fig"}, britanin strongly suppressed PGD~2~ generation and concomitantly reduced COX-2 expression. We previously reported that britanin suppresses the generations of nitric oxide by LPS and of PGE~2~ generation by COX-2 and the productions of proinflammatory cytokines by inactivating NF-κB and MAPKs in LPS-stimulated RAW 264.7 cells ([@b21-bt-22-3-193]). In addition, it has been reported COX-2-dependent PGD~2~ generation in BMMCs is caused by the activations of the NF-κB and MAPKs pathways ([@b17-bt-22-3-193]). Thus, we investigated the effect of britanin on the activations of these pathways in IgE/Ag-induced BMMCs. It is well known that IκBα phosphorylation precedes IκBα degradation via IKKα/β activation. In the present study, britanin was found to inhibit IgE/Ag-inducible IKK-IκBα phosphorylation ([Fig. 3A](#f3-bt-22-3-193){ref-type="fig"}), indicating it inhibits COX-2 dependent PGD~2~ generation by preventing the phosphorylation of IκBα, and thus, the degradation and subsequent nuclear translocation of p65 protein in BMMCs ([Fig. 3B](#f3-bt-22-3-193){ref-type="fig"}).

Furthermore, as shown in [Fig. 4](#f4-bt-22-3-193){ref-type="fig"}, britanin dose-dependently inhibited the phosphorylations of ERK1/2, JNK, and p38 MAP kinase, which suggests that it prevents the phosphorylation and translocation of cPLA~2~ to the nuclear membrane. Since both britanin and Bay 61-3606 inhibited calcium influx ([Fig. 1E](#f1-bt-22-3-193){ref-type="fig"}), MAPKs phosphorylation ([Fig. 3](#f3-bt-22-3-193){ref-type="fig"}), and the activation of the NF-κB pathway located downstream of the FcɛRI proximal Syk pathway, these results suggest that Syk plays an important roles in the generation of eicosanoids (PGD~2~ and LTC~4~) and degranulation in IgE/Ag-induced BMMCs. Because, Syk plays an essential role in the initiation of FcɛRI-dependent signaling ([@b26-bt-22-3-193]; [@b19-bt-22-3-193]), we examined whether britanin suppresses Syk phosphorylation and the expressions of its downstream signal molecules. As shown in [Fig. 5](#f5-bt-22-3-193){ref-type="fig"}, the phosphorylations of Syk, LAT, and PLCγ1 were found to be significantly inhibited by britanin and by Bay 61-3606 (a Src family kinase inhibitor and positive control).

In conclusion, the present study reveals that britanin inhibits IgE/Ag-induced degranulation and the generation of LTC~4~ and PGD~2~ in BMMCs. Furthermore, biochemical analyses showed that britanin inhibited IgE/Ag-induced degranulation via the PLCγ1-Ca^2+^ pathway, PGD~2~ production via the IKK/IκBα/NF-κB/COX-2 and MAPKs pathways, and LTC~4~ generation through the MAPKs/cPLA~2~/5-LO pathway. Furthermore, the observed almost identical effects of Bay 61-3606 suggest the inhibitory effects of britanin are controlled by the Syk pathway. In a previous report, it was suggested Syk plays a central role in the activations mediated by Fc receptors (mast cells, macrophages, neutrophils, eosinophils and basophils) and B cell receptors ([@b24-bt-22-3-193]). In addition, it has been reported that Syk inhibition blocks the release of mediators like histamine, the production of PGD~2~ and LTC~4~, and the secretions of proinflammatory cytokines from activated mast cells ([@b17-bt-22-3-193]; [@b16-bt-22-3-193]). For these reasons, Syk inhibitors are being increasingly considered promising therapeutic agents for the management of inflammatory diseases ([@b29-bt-22-3-193]; [@b1-bt-22-3-193]). Taken together with our previous *in vitro* and *in vivo* results ([@b2-bt-22-3-193]; [@b22-bt-22-3-193]; [@b15-bt-22-3-193]; [@b21-bt-22-3-193]), britanin appears to be an good candidate for the development of novel allergic-inflammatory drugs.
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![Effect of britanin on the cell viability, degranulation, PGD~2~ and LTC~4~ generation, and intracellular calcium increase in IgE/Ag-induced BMMCs. (A) BMMCs were incubated in the presence of 5, 10, or 20 μM of britanin. Cell viabilities were assayed using an MTT assay. Data represent means ± S.D of three different samples. (B) IgE-sensitized BMMCs were pre-incubated with 1 μg/ml aspirin for 2 h to abolish preexisting COX-1 activity, briefly washed, and then stimulated with DNP-HSA for 7 h. PGD~2~ released into the supernatant was quantified by a PGD~2~-MOX EIA kit and the cells were used for immunoblotting of COX-2 protein. (C) IgE-sensitized BMMCs were pre-incubated with the indicated concentrations of britanin or Bay 61-3606 for 1 h and stimulated with DNP-HSA for 15 min. LTC~4~ released into the supernatant was quantified using an enzyme immunoassay kit. (D) IgE-sensitized BMMCs were pre-incubated with the indicated concentrations of britanin or Bay 61-3606 for 1 h and stimulated with DNP-HSA for 15 min. β-Hex release in supernatants was measured as described in Materials and Methods. (E) IgE-sensitized BMMCs were pretreated with FluoForte^TM^ Dye-Loading Solution for 1 h at room temperature. After washing the dye from cell surfaces with HBSS, cells were seeded into 96-well microplates, pre-incubated with britanin or Bay 61-3606 for 1 h, and stimulated with DNP-HSA. Relative calcium levels were measured using a flurometric imaging plated reader. Values are shown as the mean ± S.D. from three independent experiments, ^\*^*p*\<0.05, ^\*\*^*p*\<0.01 and ^\*\*\*^*p*\<0.001 versus the IgE/Ag-induced group.](bt-22-3-193f1){#f1-bt-22-3-193}

![Britanin inhibits IgE/Ag-induced translocation of 5-LO and phospho-cPLA~2~. IgE-sensitized BMMCs were pre-incubated with britanin or Bay 61-3606 for 1 h and stimulated with DNP-HSA for 15 min. Cytosolic (A) and nuclear fractions (B) were immunoblotted with antibodies for phospho-cPLA~2~ (Ser505) and 5-LO. β-Actin and lamin B were used as internal controls for cytosol and nuclear fractions, respectively.](bt-22-3-193f2){#f2-bt-22-3-193}

![Inhibitory effects of britanin on IgE/Ag-induced IKK/IκBα/NF-κB pathway. (A) IgE-sensitized BMMCs were preincubated for 1 h with the indicated concentrations of britanin or Bay 61-3606 and stimulated with DNP-HSA for 15 min. Cytosol fractions were prepared for the determinations of IKKα/β and IκBα phosphorylation and total IκBα levels by immunoblotting. (B) IgE-sensitized BMMCs were pretreated with britanin or Bay 61-3606 for 1 h and stimulated by DNP-HSA for 30 min. Nuclear extracts were then analyzed by immunoblotting for the NF-κB-p65 subunit. The relative nuclear p65/lamin B protein ratios were determined by measuring immunoblot band intensities using a scanning densitometer. The results from three separate experiments as relative ratios (%) are represented. Values are shown as the mean ± S.D. from three independent experiments, ^\*\*^*p*\<0.01 and ^\*\*\*^*p*\<0.001 versus the IgE/Ag-induced group.](bt-22-3-193f3){#f3-bt-22-3-193}

![Effects of britanin on MAPK pathways. IgE-sensitized BMMCs were pre-incubated for 1 h with the indicated concentrations of britanin or Bay61-3606 and then stimulated with DNP-HSA for 15 min. Cell lysates were used immunoblotted to assess the phosphorylation of ERK1/2, JNK, and p38. The results shown represent at least three separate experiments.](bt-22-3-193f4){#f4-bt-22-3-193}

![Effects of britanin on phosphorylation of Syk, LAT and PLCγ1. IgE-sensitized BMMCs were stimulated with or without DNP-HSA for 5 min. Proteins were immunoprecipitated for Syk or LAT to assess their phosphorylation statuses. Phosphorylation of PLCγ1 was determined using total cell lysates. Blots are representative of three independent experiments that provided similar results.](bt-22-3-193f5){#f5-bt-22-3-193}
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